about
Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study.A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho.Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two yearsHome-based versus mobile clinic HIV testing and counseling in rural Lesotho: a cluster-randomized trialOutcomes of antiretroviral treatment programs in rural Southern Africa.Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled trial (CASCADE trial).Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study.Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settingsOutcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared.Accuracy of diagnostic tests for Schistosoma mansoni infection in asymptomatic Eritrean refugees: serology and POC-CCA against stool microscopy.Staphylococcus aureus Endocarditis as a Complication of Toxocariasis-Associated Endomyocarditis With Fibrosis: A Case Report.TB or not TB--Persistent cough, fever and night sweats in a 46-year-old traveler returning from South America.Metabolic syndrome in patients on first-line antiretroviral therapy containing zidovudine or tenofovir in rural Lesotho, Southern Africa.When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a prospective cohort study.Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?Clinical and socio-demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART-1.Adoption of new HIV treatment guidelines and drug substitutions within first-line as a measure of quality of care in rural Lesotho: health centers and hospitals compared.Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial.Still Far From 90-90-90: Virologic Outcomes of Children on Antiretroviral Therapy in Nurse-led Clinics in Rural Lesotho.Spectrum of infectious diseases among newly arrived Eritrean refugees in Switzerland: a cross-sectional study.Performance of Risk Charts to Guide Targeted HIV Viral Load Monitoring of ART: Applying the Method on the Data From a Multicenter Study in Rural Lesotho.Bridging the gap: how traditional healers interact with their patients. A comparative study in Cameroon.Early assessment of the implementation of a national programme for the prevention of mother-to-child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities.The treatment cascade in children with unsuppressed viral load - a reality check in rural Lesotho, Southern Africa.Prevalence rates of six selected infectious diseases among African migrants and refugees: a systematic review and meta-analysis.Provider-patient interaction in rural Cameroon--how it relates to the patient's understanding of diagnosis and prescribed drugs, the patient's concept of illness, and access to therapy.SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-laSerum 25-hydroxyvitamin D levels and intramuscular vitamin D3 supplementation among Eritrean migrants recently arrived in Switzerland.Performance of the point-of-care circulating cathodic antigen (POC-CCA) urine cassette test for follow-up after treatment of S. mansoni infection in Eritrean refugeesSocial Resilience and Mental Health Among Eritrean Asylum-Seekers in SwitzerlandEffect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical TrialPEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural LesothoCardiovascular diseases risk factors among recently arrived Eritrean refugees in SwitzerlandEffect and cost of two successive home visits to increase HIV testing coverage: a prospective study in Lesotho, Southern AfricaEngagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trialChanging Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up EraSeroprotection rates of vaccine-preventable diseases among newly arrived Eritrean asylum seekers in Switzerland: a cross-sectional studyThe HOSENG trial - Effect of the provision of oral self-testing for absent and refusing individuals during a door-to-door HIV-testing campaign on testing coverage: protocol of a cluster-randomized clinical trial in rural LesothoVIBRA trial - Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural LesothoGlycaemic control among patients with type 2 diabetes followed in a rural African primary care setting - A reality check in the Democratic Republic of Congo
P50
Q30869396-2CB76F7D-CB98-4F8B-86E3-3C0DDDB41BEFQ34464667-2A350E4F-6E29-41CE-9775-86134BD57BD8Q34478277-72EA9212-00D1-4AED-B879-A17C73EEE058Q34713144-EEB813E0-63A8-44EE-B95A-1ECAA9C84878Q35675233-B9AD0B86-6569-4305-86A2-45CF86766500Q35990384-510401A9-599A-4C8B-84A0-A75B65710597Q36127177-850421D7-CD65-44BE-9476-E463BDF85677Q37116750-4CB8C979-4283-40A4-813D-AE1BE5BB66B7Q37337527-20BB0115-0532-4DC0-8F42-B2B5627F8968Q38943456-A13F8AF1-15BB-4EC1-ABCD-F54F0F30E609Q39150156-FB19C278-4108-4CF8-9465-6A303A5347CEQ39155372-D46A1CAA-138E-497A-94E3-4CED67C2FB6DQ39155380-012F0CBE-07CE-4ED3-A131-C4963D941FC9Q39155386-4092DCDB-9F5D-4C3A-81EC-E270D600BF92Q39155393-2127DCDA-A500-4118-913D-97F2E4AA5BE9Q39155400-DB981F34-370F-4704-90A0-C9E40123F538Q39155410-1C425D40-6A3F-499B-929F-4DC7BB027FF0Q39155416-6D1D805A-0AA6-4871-896D-3D09365AC7B4Q39370726-369D7439-B107-452A-BB1D-18D4987CDA53Q41996652-76CD592B-31E8-4790-919F-B47822656738Q43809022-BBF4FE0E-BDE5-4D75-9AC2-EA0B7972AF8EQ44539532-13E0C95B-7D13-43A6-97D9-8C6C8477FC44Q44554689-E9C2CB69-B2AA-42AA-9BA7-FF65E53E8C4BQ46162228-B72385DF-7011-4CC8-A184-BE691C6FF8A5Q46748947-27F8A01D-C2DE-43DF-AE55-92EB901B5682Q46814599-5B760B35-3B8C-4AC9-A862-808A85A74231Q49344179-1DE48A9E-48FD-4087-8F98-A979AE2559B1Q49544192-97203E6B-11F1-4DDF-AFC0-563E42A8C152Q58206644-BC16E0A3-D4E9-48FC-84FC-635BBEA9D35FQ58206647-2314D519-83D0-412D-96BD-45BD9BED5A7BQ58206653-3381715E-7565-4E3B-A2F2-25D7A6E90FA3Q90759846-97B1E050-4846-4D22-9B69-66522C282A24Q90872534-87335EE9-29F5-461F-AFA1-B53B681BFE97Q91059257-9FB11C88-007E-45C5-8CCC-7F482FF82A4DQ91536044-4DCC9CF5-6355-4E2A-9097-589F942A4E4DQ91547017-085BA746-5A5D-4547-AA6B-AE8A989C484BQ92065972-75331091-B8C2-4A28-8ED3-CAB655B761FAQ92599869-30AEFA20-A6E3-4A7B-8B45-C144AD44E3AFQ92787725-4B422EA3-E066-474C-8591-3F650AC4C5B1Q92911570-3E2E109A-0908-4F6B-838B-3FCBD9E17CDC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Niklaus Daniel Labhardt
@ast
Niklaus Daniel Labhardt
@en
Niklaus Daniel Labhardt
@es
Niklaus Daniel Labhardt
@nl
Niklaus Daniel Labhardt
@sl
type
label
Niklaus Daniel Labhardt
@ast
Niklaus Daniel Labhardt
@en
Niklaus Daniel Labhardt
@es
Niklaus Daniel Labhardt
@nl
Niklaus Daniel Labhardt
@sl
prefLabel
Niklaus Daniel Labhardt
@ast
Niklaus Daniel Labhardt
@en
Niklaus Daniel Labhardt
@es
Niklaus Daniel Labhardt
@nl
Niklaus Daniel Labhardt
@sl
P106
P1153
25960132600
P21
P31
P496
0000-0003-3599-1791